Literature DB >> 19355955

Cardiovascular disease: an economical perspective.

A Lazzini1, S Lazzini.   

Abstract

Cardiovascular diseases represent a relevant problem worldwide. Data from World Health Organization (W.H.O.) demonstrate that they are one of the principle causes of death: 30% of all losses of human life throughout the world are due to heart diseases. Such data buries a substantial economic cost considering both the direct component, first of all the national health expense, and the indirect part, such as absenteeism rate, productivity loss, quality of life and, more generally, social costs. The future scenario pictured by the W.H.O. reveals a negative trend due to an increasing in the rate of morbidity and mortality especially in Emerging Countries. One of the solution to stem the costs - economic and not - connected to cardiovascular diseases is to empower the prevention activities overall the actions of primary prevention. This require a change in the traditional patient-physician relationship management model to get to an organizational model centred on patient and based on a proactive approach. In this perspective in the paper will be analysed the principal changes that occurred in the Italian national healthcare system and in particular the strategic plans and actions in theme of cardiovascular prevention.

Entities:  

Mesh:

Year:  2009        PMID: 19355955     DOI: 10.2174/138161209787846883

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta.

Authors:  Mamadou Sarr; Saliou Ngom; Modou O Kane; Alassane Wele; Doudou Diop; Bocar Sarr; Lamine Gueye; Ramaroson Andriantsitohaina; Aminata S Diallo
Journal:  Nutr Metab (Lond)       Date:  2009-11-02       Impact factor: 4.169

2.  The prevalence of major cardiovascular risk factors in a rural population of the Chui region of Kyrgyzstan: The results of an epidemiological study.

Authors:  Andrey G Polupanov; Abdimetalip Khalmatov; Aliina Altymysheva; Olga S Lunegova; Aibek E Mirrakhimov; Ibragim S Sabirov; Anna Kontsevaya; Ainagul Dzhumagulova; Erkin Mirrakhimov
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.